Clinical Trials Browser

Phase NA × Recruiting × Lymphoproliferative Disorders × Clear all

Lymphoproliferative Disorders, Myeloproliferative Disorders

NCT05898789 2026-02-25

Virtual Rehabilitation for Cancer Survivors

BreastGastrointestinalHead & NeckLymphoid

Breast Carcinoma In Situ, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Lymphoproliferative Disorders, Colorectal Neoplasms

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Phase NA Recruiting

82 enrolled

LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Phase NA Recruiting

83 enrolled

Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

Clinical Trials

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Virtual Rehabilitation for Cancer Survivors

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma